Dawes Karen A

Avg. Two Year Performance

174% Avg. Purchase Return
65% Compound
(12%) Avg. Sale Return
(6%) Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return2%(1%)14%54%174%
Purchase Success Rate6 of 83 of 85 of 87 of 87 of 8
Average Sale Return(5%)(9%)(21%)(4%)(12%)
Sale Success Rate3 of 150 of 150 of 150 of 150 of 15
Drugs » Biotechnology

Chairperson of the Board, Director:

Holdings: 2.25K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Drugs » Biotechnology

Director:

Holdings: 88.17K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Other » Other

Director:

Holdings: 84.59K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Other » Other

Director:

Holdings: 1.7K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--